Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00767884 · ClinicalTrials.gov registry record
Effect of Panretinal Photocoagulation on Optic Nerve Head Topography
A clinical trial, sponsored by University of Nebraska.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00767884: Clinical Trial study, sponsored by University of Nebraska.
NCT00767884 is a clinical trial that was terminated before completion, run by University of Nebraska. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00767884 was terminated before completion, sponsored by University of Nebraska.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the optic nerve head changes consequent to panretinal photocoagulation done for diabetic retinopathy.
Primary Outcome
Compare changes in optic nerve head topography before and after panretinal photocoagulation (PRP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2008-10-29 |
| Est. Completion | 2013-10-17 |
Why NCT00767884 stopped before completion
NCT00767884 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00767884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00767884 about?
NCT00767884 is a clinical study titled "Effect of Panretinal Photocoagulation on Optic Nerve Head Topography". The purpose of this study is to evaluate the optic nerve head changes consequent to panretinal photocoagulation done for diabetic retinopathy.
What is the current status of trial NCT00767884?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2008-10-29. Estimated completion is 2013-10-17.
Who is sponsoring clinical trial NCT00767884?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI